Associated Papers
A Transgenic Mouse Model of Pacak⁻Zhuang Syndrome with An Epas1 Gain-of-Function Mutation.
Wang H et al.
Cancers, 2019
HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven disease.
Tarade D et al.
Nature Communications, 2018
30135421 (PubMed )
Supplement: 41467_2018_5554_MOESM1_ESM.pdf
New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas.
Toledo RA
Endocrine-related Cancer, 2017
HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma.
Zhuang Z et al.
Endocrine-related Cancer, 2016
Select a paper to view details